Aspen Holdings closed multi-currency syndicated facilities equivalent to approximately €3.4 billion ($4 billion). MUFG and Nedbank served as global coordinators, initial mandated lead arrangers and bookrunners.
The facilities were structured across euro, South African rand and Australian dollar term and revolving credit facilities with tenors of two to four years with a one-year extension option. All facilities were consolidated into a single facility agreement with lenders ranking pari-passu.
MUFG Bank acted as the euro and AUD coordinator, arranger, bookrunner and documentation agent. Nedbank acted as euro and rand coordinator, arranger, bookrunner and publicity agent.
Twenty-eight lenders committed to the facilities from across the U.S., Europe, Africa, Australia and Asia.
The facilities are guaranteed by Aspen Pharmacare Holdings, Pharmacare, Aspen Global, Aspen Asia Pacific, Aspen Finance, Aspen Nutritionals Australia, Aspen Pharmacare Australia, Aspen Pharma and Orphan Holdings.
The mandated lead arrangers and bookrunners are ABSA Bank, Bank of America Merrill Lynch, BNP Paribas, Citi Bank, FirstRand Bank, Investec Bank, Mizuho Bank, JPMorgan, London Branch, Standard Chartered Bank, Standard Finance (Isle of Man), The Standard Bank of South Africa and Sumitomo Mitsui Banking.
Aspen provides specialty and branded pharmaceuticals with an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life.